531 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Ovarian Diseases" (531 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
3 Recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
4 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
5 Not yet recruiting Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Intervention: Biological: Prolanta, a human prolactin receptor antagonist
6 Recruiting A Mind-body Intervention to Improve Body and/or Self Image
Conditions: Breast Cancer;   Ovarian Cancer;   Uterine Cancer;   Cervical Cancer
Interventions: Behavioral: Hypnotic Relaxation Therapy;   Behavioral: Progressive Muscle Relaxation
7 Not yet recruiting Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer
Conditions: Fallopian Tube Carcinoma;   Ovarian Carcinoma
Intervention: Procedure: Photoacoustic Imaging
8 Not yet recruiting Mesenchymal Stem Cells (MSC) for Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: MSC-INFβ;   Behavioral: Questionnaires
9 Recruiting WISER After Ovarian Cancer - Exercise Pilot Study
Condition: Ovarian Cancer
Intervention: Behavioral: Exercise
10 Not yet recruiting Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial Cancer
Condition: Ovarian Neoplasms
Intervention:
11 Not yet recruiting Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Metformin;   Dietary Supplement: Magnesium;   Dietary Supplement: PUFA
12 Not yet recruiting Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Ovarian Cancer;   Metastatic Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pembrolizumab
13 Recruiting Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Conditions: Adnexal Mass;   Borderline Ovarian Epithelial Tumor;   Ovarian Clear Cell Tumor;   Ovarian Endometrioid Tumor;   Ovarian Neoplasm;   Ovarian Serous Tumor;   Recurrent Ovarian Carcinoma
Interventions: Drug: Dexamethasone;   Other: Laboratory Biomarker Analysis;   Drug: Valproic Acid
14 Recruiting Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity
Condition: Ovarian Epithelial Cancer
Intervention: Procedure: Lavage of the Cavum uteri and proximal fallopian tubes
15 Recruiting Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers
Condition: Hereditary Breast and Ovarian Cancer
Intervention: Behavioral: Structured exercise training plus mediterranean diet
16 Recruiting Effect of Vitamin D on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Other: Vitamin D3, 3200IU;   Other: Placebo
17 Recruiting NAFLD in Adolescents and Young Adults With PCOS
Conditions: Polycystic Ovary Syndrome;   Non-Alcoholic Fatty Liver Disease;   Metabolic Syndrome
Intervention: Other: There is no intervention
18 Not yet recruiting C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
Condition: "Ovarian Cancer", "Hereditary Ovarian Cancer Syndrome"
Intervention:
19 Not yet recruiting Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Clear Cell Adenocarcinoma;   Fallopian Tube Endometrioid Adenocarcinoma;   Fallopian Tube Mucinous Adenocarcinoma;   Fallopian Tube Serous Adenocarcinoma;   Fallopian Tube Transitional Cell Carcinoma;   Malignant Ovarian Mixed Epithelial Tumor;   Ovarian Clear Cell Adenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mucinous Adenocarcinoma;   Ovarian Serous Adenocarcinoma;   Ovarian Transitional Cell Carcinoma;   Primary Peritoneal Serous Adenocarcinoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Undifferentiated Fallopian Tube Carcinoma;   Undifferentiated Ovarian Carcinoma
Interventions: Drug: Cediranib Maleate;   Other: Laboratory Biomarker Analysis;   Drug: Olaparib;   Drug: Paclitaxel;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride;   Other: Questionnaire Administration;   Drug: Topotecan Hydrochloride
20 Recruiting Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Non-Alcoholic Fatty Liver Disease;   Metabolic Syndrome
Interventions: Drug: Metformin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years